# SOP Review and Approval Workflow for Microbiology Labs: Who Signs Off A structured SOP review and approval process turns a bench procedure from one person's habit into a controlled, verifiable instruction that any qualified technologist can follow and that an inspector can trace back to named, accountable reviewers. In a microbiology laboratory, this workflow governs everything from Gram stain technique and blood culture broth subculture rules to antimicrobial susceptibility testing interpretation and the handling of select agents. When it is done well, the laboratory can demonstrate to a surveyor exactly who wrote each procedure, who checked its technical accuracy, and who authorized it for use. This guide covers when the workflow applies, who must sign off at each stage, a step-by-step procedure for running the process, troubleshooting for the failure modes that stall document pipelines, and the mistakes that most often surface during accreditation inspections. It is written for working microbiology laboratories, including clinical, public health, and veterinary diagnostic labs. **Time commitment.** Authoring a new method SOP typically takes the writer 4 to 8 hours of focused bench-side work, including pulling manufacturer instructions, current CLSI breakpoints, and validation data. Technical and quality review each add 1 to 3 hours of reviewer time. Elapsed time from first draft to effective date is realistically 2 to 6 weeks in a lab that meets weekly on documents, and longer if the laboratory director signs only on a set day each month. A periodic review of an unchanged SOP, meaning a read-through and re-signature with no edits, takes about 30 to 60 minutes total. ## What the Review and Approval Process Actually Governs The principle behind document review and approval is simple. An SOP is a controlled record, and like any record in laboratory quality management, it must have a defined owner, a defined check, and a defined authority. Guidance on SOP lifecycle management describes review and approval as a distinct phase that follows drafting and precedes distribution, with named individuals accountable at each stage. The review step asks whether the document is technically correct and complete. The approval step asks whether the organization accepts responsibility for the document as written. These are different questions, and they are answered by different people. This separation matters because of how errors actually propagate. A study of standardized process mapping in hospital discharge workflows found that poorly defined procedures and inconsistent adherence to them were major contributors to delays and compromised care quality, and that structured standardization reduced turnaround time and improved workflow [1]. A microbiology analog is easy to construct. If the incubation time for anaerobe hold plates is ambiguous, one shift reads at 24 hours and another at 48 hours, and anaerobe recovery differs by shift in a way no one can explain during a workup of a discrepancy report. The review and approval process also feeds microbiology quality control directly. An approved SOP defines the control materials, acceptance criteria, and corrective actions for each method. If the SOP is wrong, the daily quality control performed under it inherits the error. Document control is therefore the quality control of the quality system itself. ## Who Signs Off: Signature Roles and What Each Reviewer Owns ![Five-step flow from author draft through technical, biosafety and quality review to director approval, with the author barred from final approval.](/article-images/illustrations/sop-review-and-approval-process-sop-signature-chain.webp) The core answer to the question in the title is that a minimum of three roles must sign, and in most clinical settings four do. The exact titles vary between organizations, but the functions do not. Table 1 maps the roles. | Role | Who typically holds it | What their signature means | Required for | |--|--|--|--| | Author | Senior technologist or microbiologist who performs the procedure | The content reflects current bench practice and supporting references | Every SOP | | Technical reviewer | Section supervisor, specialist microbiologist, or lead technologist not primarily responsible for the draft | An independent qualified person has verified the technical content, references, and calculations | Every SOP | | Quality manager | The designated quality manager or quality officer | The document meets format, document control, and quality system requirements | Every SOP | | Laboratory director | CLIA-qualified director or designated deputy | The organization accepts the procedure, including any policy affecting reported patient results | Policies, interpretation criteria, reportable-range changes, and any SOP with direct patient-result impact | | Biosafety officer | Laboratory biosafety officer or safety designee | [Biosafety levels](/knowledge/diagnostics/emerging-tech/biosafety-levels-1-4-a-decision-framework-for-diagnostic-laboratories), PPE requirements, and decontamination steps are appropriate | SOPs involving specimen handling, cultures, or hazardous reagents | Two principles govern the signature block. First, the author must not be the final approver. A self-approved document defeats the purpose of independent review, a point made explicitly in published guidance on SOP review and approval. Second, the approver of last resort must have the authority to enforce what the SOP says. In US clinical laboratories, the laboratory director holds overall responsibility for the quality system, so policies that change what gets reported to clinicians, such as new antimicrobial interpretation criteria or a change in organism reporting rules, need the director's signature or the signature of a formally delegated qualified designee. Harmonization thinking from the regulatory world is useful here. Analyses of drug approval frameworks across authorities note that consistent, documented review standards reduce complexity and improve predictability, which is why international harmonization efforts aim to align review criteria across jurisdictions [2]. Inside a single laboratory, the same logic applies. If every SOP follows the same signature sequence and the same review checklist, reviewers stop negotiating process and start evaluating content. ## Materials and Document Control Tools The workflow runs on documents and systems rather than reagents, but the same discipline applies. Table 2 lists what a laboratory needs in place before the first draft circulates. | Item | Specification or format | Purpose | |--|--|--| | SOP template | Header with document number, version number, effective date, supersedes field, page x of y, and a signature block with printed name, signature, and date lines for each role | Forces completeness and makes version identity unambiguous at a glance | | Document numbering scheme | A fixed convention, for example MICRO-BACT-014, where the middle segment identifies the section | Prevents duplicate numbers and lets auditors trace documents by area | | Master document list or index | A controlled spreadsheet or the index module of the quality management software | The single authoritative record of which version of which SOP is currently effective | | Review checklist | One page listing the checks in the step-by-step section below | Makes the technical review reproducible and auditable | | Document management system or controlled network folder | Read-only access for bench staff, edit access limited to the quality unit | Prevents uncontrolled local copies from circulating | | Change request form | Short form capturing the reason for change, affected documents, and training required | Creates the audit trail connecting a change to its justification | | Training record system | Signature-based or electronic attestation tied to each SOP version | Demonstrates that staff were trained on the exact version in force | | Current references at hand | Manufacturer package inserts, current CLSI breakpoint tables, biosafety manuals | Review must happen against the current editions, not last year's | A safety note belongs here. Any SOP that describes handling of cultures, specimens, or hazardous reagents should be drafted with the [biosafety manual](/knowledge/diagnostics/emerging-tech/biosafety-manual-development-a-template-for-diagnostic-laboratories) open, and the reviewer should confirm that the [biosafety level](/knowledge/diagnostics/emerging-tech/biosafety-levels-1-4-a-comparative-framework-for-diagnostic-laboratory-design), required PPE, and decontamination method match the agent and the procedure. Reviewing the technical steps without reviewing the exposure risk is an incomplete review. ## The SOP Review and Approval Process Step by Step The sequence below is the standard SOP review and approval process step by step for a microbiology laboratory. Each step includes the reason it exists, because a reviewer who understands the reason performs the check better than one who signs out of habit. 1. **Author drafts the SOP on the current template.** The author writes from direct bench knowledge and attaches the primary sources, including the manufacturer insert, the current CLSI standard or breakpoint table in force, and any internal validation summary. The reason for attaching sources is that the technical reviewer must be able to verify claims against primary documents rather than trust the author's memory. 2. **Author performs a self-check against the template and checklist.** Before anyone else sees the draft, the author confirms that every section is complete, that volumes, temperatures, times, and acceptance criteria are stated as values rather than adjectives, and that obsolete cross-references have been updated. This step exists because reviewer time is the scarcest resource in the workflow, and drafts that arrive incomplete waste a full review cycle. 3. **Submit to the quality unit for a format and routing check.** The quality manager or designee confirms the document number, version, header fields, and cross-references are correct and logs the document as under review. The reason is that format problems found early cost minutes, while the same problems found after technical review cost a second full cycle. 4. **Technical review by a qualified independent reader.** The technical reviewer works through the SOP against the bench reality, checking that the steps describe what actually happens, that the referenced standards are current editions, and that calculation examples, if present, are correct. Published guidance on SOP review and approval frames this as the point where an independent, competent person verifies content before the organization commits to it. The independence requirement is the reason this signature cannot go back to the author. 5. **Biosafety and, where relevant, informatics review.** For SOPs that change specimen handling, incubation, disposal, or agent workup, the biosafety officer signs the review block. For SOPs that change how results appear in the laboratory information system, an informatics reviewer confirms the build matches the SOP. These reviews exist because a technically perfect SOP that creates an exposure risk or a report mismatch is still a defective document. 6. **Resolve comments in writing.** The author responds to each reviewer comment on a comment-resolution log, marking each item as accepted, accepted with modification, or declined with rationale. The reason for the written log is that a surveyor may later ask why a reviewer's concern was not adopted, and the log is the answer. 7. **Quality review.** The quality manager verifies that the template is complete, the signature block names all required roles, the document language is consistent with the rest of the manual, the change request is attached, and the training plan is identified. Quality review is a conformance check, not a second technical review, and keeping the two separate prevents duplicated effort. 8. **Laboratory director approval where required.** The director or delegated designee reviews the summary of changes and signs for any SOP that affects reported results, reportable ranges, referral testing, or laboratory policy. Many directors delegate day-to-day method SOPs to supervisors and reserve their own signature for policy-level documents. Whatever the arrangement, it must be written in the delegation record, because an undocumented delegation fails an inspection as surely as a missing signature. 9. **Assign effective date and version number.** The quality unit sets the effective date, typically after training is complete, increments the version, and records the superseded version number. The reason the effective date follows training rather than the other way around is that staff must never be accountable to a procedure they have not been trained on. 10. **Train affected staff and collect attestations.** Staff read the new version, and the trainer demonstrates or observes any changed hands-on step. Each staff member signs or electronically attests to training on that specific version. Implementation research on SOP adherence shows that consistent technical execution depends on training and supervisory follow-through, not on the existence of the document alone [3]. The attestation is what closes the loop between an approved document and competent performance. 11. **Distribute controlled copies and withdraw obsolete ones.** The quality unit publishes the SOP to the controlled location, removes the prior version from bench binders, and marks withdrawn paper copies as obsolete. The reason is the classic document-control failure in which a technologist follows a superseded version left in a drawer during an inspection. 12. **Set the next periodic review date.** The master list records the review-due date, commonly annual, with the exact interval set by the laboratory's quality plan and accreditation requirements. Written guidance on SOP lifecycle management treats periodic review as a mandatory scheduled event rather than an optional one. The 2026 EULAR standard operating procedures for developing recommendations describe the same concept as a living document, updated on a defined cycle as evidence and practice change [4]. The reason for a fixed date is that review programs without dates degrade into review programs without reviews. 13. **File the complete review packet.** The draft, comment log, checklist, all signatures, the training records, and the superseded version are archived together. The reason is that the packet is the evidence. A signature without its supporting packet proves little during an audit. A realistic target cycle for a noncontroversial method SOP in a well-run lab is 2 to 6 weeks of elapsed time. Duration data from an entirely different review domain illustrate why laboratories should track their own timelines rather than assume them. In a multicenter study of ethics approval durations, the mean time for secondary approvals was 53.6 days with a standard deviation of 49.8 days and a median of 34 days, showing how widely review turnaround can vary even within one system [5]. Labs that measure their own review turnaround usually find a similar pattern, where the mean is inflated by a few documents that stall for months on a single signature. ## SOP Review and Approval Process Tips These tips come from the practical constraints that shape how the sop review and approval workflow for microbiology labs actually runs. - **Batch reviews on a fixed calendar.** Directors and technical reviewers sign in batches. Scheduling a monthly document meeting converts an unpredictable interruption into a predictable pipeline, and it mirrors the way structured review scheduling improves throughput in other regulated review processes [6]. - **Write the review checklist once and use it every time.** A one-page checklist covering template completeness, reference currency, biosafety, informatics impact, and training plan makes technical review transferable when the usual reviewer is on leave. - **Cap comment cycles.** Two full revision cycles is a workable limit, after which the author, reviewers, and quality manager meet and settle remaining points live. Narrative reviews of approval inefficiencies in other regulated fields identify prolonged, iterative reviewer exchanges as a principal driver of delay [7]. The same dynamic stalls laboratory documents that ping-pong between reviewers by email for months. - **Review against the current manufacturer insert and current breakpoints.** Antimicrobial susceptibility SOPs age fastest because breakpoints change. The technical review should confirm that the version of the interpretive criteria named in the SOP is the version the laboratory intends to use. - **Keep a change log inside the SOP.** A table at the end listing version, date, section changed, and reason lets a reviewer orient in seconds and lets an inspector confirm that changes match the change request. - **Use the master list as the single source of truth.** If the master document list and a bench binder disagree, the master list wins, and the binder is corrected the same day. ## Controls, Expected Results, and How to Read Your Document Control System In microbiology quality control, a control tells you whether the analytical system behaved as expected. In document control, the equivalents are the records the workflow generates. A laboratory should be able to produce the following on request during an inspection, and each item is a control with an expected result. - **Signature block with all required roles.** Expected result, every SOP effective in the laboratory carries dated signatures from the author, an independent technical reviewer, the quality manager, and the director or designee where required. A missing signature is a failed control. - **Version identity at the point of use.** Expected result, the copy a technologist opens at the bench matches the effective version in the master list. A mismatch is a failed control. - **Training attestations preceding the effective date.** Expected result, every staff member performing the procedure has a dated attestation for the current version. - **Comment-resolution log.** Expected result, every reviewer comment has a documented disposition. - **Review-due tracking.** Expected result, no SOP on the master list shows an overdue review date at the time of an inspection, or any overdue item has a documented remediation plan. Reading these controls is straightforward. Auditors typically sample documents, trace one from the master list to the bench copy and back through its signatures and training records. If the chain holds for the sampled documents, the document system passes. Post-approval follow-through determines whether the system stays healthy, a lesson visible in regulated product surveillance, where an analysis of FDA post-approval study orders for transvaginal mesh devices found that compliance failures and market withdrawal, not approval itself, determined the ultimate safety profile of the devices [8]. The laboratory parallel is that the approval signature starts accountability rather than ending it, and the periodic review is where that accountability is exercised. ## Troubleshooting the Workflow | Symptom | Likely cause | Fix | |--|--|--| | Drafts sit with a reviewer for months | No fixed review calendar, no escalation path | Batch monthly reviews, add a standing agenda item, escalate documents open past two cycles to the director | | Reviewers return contradictory comments | Reviewers are checking different things, or no checklist exists | Adopt a single checklist, assign each reviewer a defined scope, hold one comment-resolution meeting | | Signatures appear within minutes of submission | Approval without reading, often under inspection pressure | Reinforce that reviewers own the content, spot-check by asking reviewers to summarize the change they approved | | Staff follow two different versions at the bench | Obsolete copies not withdrawn, or personal copies circulating | Audit bench locations, remove uncontrolled copies, publish only through the controlled system | | Training records postdate the effective date | Effective date set before training completed | Change the workflow order so training always precedes the effective date, then correct the affected records | | Auditor flags an SOP missing the director signature | Delegation limits unclear or undocumented | Write the delegation record, then route policy-level documents to the director and method SOPs to the delegate | | Two SOPs contradict each other, for example on colony counting | Documents revised independently with no cross-impact check | Add an affected-documents search to the change request step before any revision is approved | | Annual reviews all come due the same month | All documents created at once during initial accreditation | Stagger review-due dates by spreading effective dates across the year during the next review cycle | ## Variations on the Standard Workflow ![Decision path asking whether the change affects reported results, then whether it is urgent, leading to a change memo or the full review cycle.](/article-images/illustrations/sop-review-and-approval-process-urgent-change-path.webp) **Small laboratories.** In a lab with one microbiologist and a generalist director, the author, technical reviewer, and quality functions may be held by two or three people. The functions must still be separate even when the people are few, meaning the person who wrote the SOP cannot be the person who approves it, and the independence of the technical review must be real. Published guidance on SOP review and approval is explicit that author and final approver must be different individuals. **Electronic signatures and document management systems.** Many laboratories run the entire workflow in a quality management system with role-based electronic signatures. The advantages are automatic version control, enforced routing, and an unalterable audit trail. The requirements that do not change are independence of review, documented delegation, and training tied to the version. The implementation challenges seen in electronic review systems elsewhere, including reviewer availability and workload during peak periods, apply to laboratory eQMS rollouts as well, so the fixed calendar matters even more, not less [6]. **Urgent changes.** During an outbreak investigation, a reagent shortage, or a manufacturer recall, a laboratory may need to change a procedure before the full cycle can run. The accepted variation is a short-term change memo, signed by the director or designee, that states the interim instruction, its justification, and its expiry date, with the full SOP revision required before the memo expires. The memo is filed with the SOP record. The conditional approval models used in drug regulation, where time-limited authorization is paired with mandatory follow-up commitments, illustrate the same structure of interim authority with a defined endpoint [9]. **Method changes versus policy changes.** A reagent lot change that alters no reported result may need only technical and quality review. A change to what organisms are reported, which antimicrobials are included on a panel, or how results are interpreted changes patient care and requires director sign-off. Writing this distinction into the quality manual removes the daily guesswork. **Multi-site and network laboratories.** Networks that standardize SOPs across sites borrow directly from the harmonization approach used by global regulatory bodies, which coordinate differing national requirements toward common standards [2]. The practical requirement is a designated lead site that owns the master document and a defined route by which any site can propose a change. ## Storage, Retention, and Stability of Approved Documents Approved SOPs are stored as controlled masters, readable by all staff and editable only by the quality unit. The master list, the current versions, and the archived packets of superseded versions are all part of the record. Superseded versions are retained according to the laboratory's retention schedule and applicable regulatory requirements, and they are stored with a visible obsolete watermark so they cannot reenter circulation. Electronic archives should preserve the signed PDF or equivalent, because an unsigned working file is not the controlled record. Stability in this context means reference currency rather than chemical stability. A signature does not freeze the science. Breakpoint tables, manufacturer instructions, and biosafety guidance all change, and the SOP inherits the oldest of them unless the review cycle catches up. This is the reasoning behind the living document model, in which procedures are revised on a defined cycle rather than held fixed until they fail [4]. For a microbiology laboratory, the practical translation is that susceptibility and identification SOPs deserve the tightest review intervals and the closest tracking of external reference updates. A brief safety note on storage, paper SOPs stored in laboratories where cultures are handled should be protected from splashes and contamination, and any SOP page that becomes contaminated with clinical material is discarded as biohazardous waste and replaced from the controlled master. ## Common Mistakes and Limitations These are the specific, recurring errors in the sop review and approval process, phrased so a laboratory can check itself against each one. - **Author self-approval.** The single most common deficiency. It removes the independent check that the process exists to provide. - **Approval by title without content review.** A director who signs a stack of SOPs in five minutes is signing documents, not reviewing procedures. Reviewers who cannot summarize what changed did not review it. - **Effective date before training.** Staff then work for days under a procedure they have not been trained on, and the training records contradict the document history. - **Reviewing the draft instead of the bench.** A reviewer who reads the document at a desk without comparing it to what happens at the bench approves a fiction. Process-mapping studies in clinical settings show that the gap between written procedure and actual practice is precisely where quality failures hide [1]. - **No comment-resolution record.** Disagreements settled by conversation and forgotten are disagreements an auditor will reopen. - **Cross-references left stale.** An SOP that points to a superseded version of a related procedure creates two controlled documents that contradict each other. - **SOPs that describe ideals rather than practice.** Implementation research on SOPs in service settings found that staff adhered well to explicitly written technical steps but struggled with unwritten behavioral expectations, and that gaps between the document and reality eroded effectiveness [3]. Microbiology SOPs written for surveyors rather than technologists produce the same failure. - **Annual reviews performed as signature renewals.** Re-signing without reopening the document and checking current references converts the periodic review into a rubber stamp. - **Uncontrolled personal copies.** Printed SOPs in bench drawers are the classic inspection finding. - **Overdue review dates with no remediation.** An overdue document with a documented plan is defensible. An overdue document nobody noticed is a failed system. One limitation deserves an honest statement. The signatures prove that qualified people reviewed and accepted a document. They do not prove that the procedure is being performed correctly today, and they do not substitute for competency assessment, proficiency testing, or direct observation. Document approval and personnel competency are separate pillars of laboratory quality management, and a deficiency in one cannot be signed away by the other. ## Where This Fits in Laboratory Quality Management The SOP review and approval process is one element of the broader quality management cycle of plan, do, check, act. Within that cycle, the approval workflow is the checkpoint between planning a process and doing it, and the periodic review is the check that closes each cycle. Laboratories that map their document workflow explicitly, the way process mapping has been applied to reduce turnaround times in hospital operations, gain measurable control over their review pipeline and can see bottlenecks that are invisible in ad hoc email routing [1]. Structured protocols and continuous monitoring, rather than one-time cleanup projects, are what make the improvement durable. For microbiology specifically, the document system carries extra weight because the discipline's outputs are interpretive. A susceptibility category, an organism name on a report, and a colony-count threshold are all policy decisions embedded in SOPs, which is why the director's signature on interpretation documents is not a formality. The review and approval workflow is where the laboratory decides, on the record and with named accountability, what it will tell clinicians and how. ## Frequently Asked Questions ### Can the person who writes an SOP also approve it? No. The author must not be the final approver, because the approval step exists to provide an independent organizational check on the document. Guidance on SOP review and approval treats the separation of author and approver as a basic requirement, and a self-approved SOP is a predictable inspection finding. ### Does the laboratory director have to sign every SOP? No, not in most laboratories. Directors typically sign policies, interpretation and reporting criteria, and documents with direct impact on patient results, while delegating routine method SOPs to qualified supervisors. The delegation must be documented, and any SOP affecting reported results should carry the director's signature or that of a formally delegated designee. ### How often must an SOP be reviewed even if nothing changed? The review interval is set by the laboratory's quality plan and its accreditation and regulatory requirements, and annual periodic review is the most common arrangement. The key point is that the review date must be tracked on the master document list, because an undocumented interval reliably degrades into no review at all. ### What is the difference between review and approval? Review verifies that the document is technically correct, complete, and safe. Approval records that the organization accepts the document and authorizes its use. The same person can sometimes perform both checks only if they hold both roles, but the author can hold neither of the final signatures. ### Can we use electronic signatures instead of wet ink? Yes, provided the system enforces role-based routing, captures the identity and date of each signature, and preserves an audit trail. Electronic signature systems add version control and eliminate lost paper, but they do not remove the independence, delegation, and training requirements that make a signature meaningful. ### What do we do when a change is needed before the annual review? Use a short-term change memo signed by the director or delegated designee, stating the interim instruction, the justification, and an expiry date, then complete the full SOP revision before the memo expires. File the memo with the SOP record so the document history remains complete. ### Who approves an SOP for a send-out or reference test? The referring laboratory still needs a controlled SOP describing specimen requirements, transport, ordering, and result handling, and it follows the same signature chain as any method SOP. The reference laboratory's own procedure is outside your document system, so your SOP describes what your laboratory does, not what the reference laboratory does. ### How do we handle an urgent procedural change during an outbreak or survey? Follow the short-term change memo pathway immediately, with director or designee sign-off and a stated expiry date. Schedule the permanent revision into the next review cycle, and record the interim memo in the change log so an auditor can trace the sequence of authority. ## Sources 1. [Improving Discharge Efficiency through Standard Operating Procedures Mapping and Standardisation: A Narrative Review](https://doi.org/10.7860/jcdr/2025/81593.21929) 2. [Global Analysis of Regulatory Frameworks and Drug Safety Standards in the Drug Approval Process.](https://pubmed.ncbi.nlm.nih.gov/40916422/) 3. [Implementation of Waiter Service Standard Operating Procedures (SOP) in Improving Service Effectiveness at Boulevard Bistro Restaurant, Lion Hotel & Plaza Manado](https://doi.org/10.29303/intour.v4i2.2506) 4. [2026 EULAR updated standardised operating procedures and methods for the development of recommendations or points to consider for the diagnosis and management of people with rheumatic and musculoskeletal diseases.](https://pubmed.ncbi.nlm.nih.gov/42502008/) 5. [[Duration and variation of the ethics approval process in Germany - an example from a non-interventional study with 44 participating centers].](https://pubmed.ncbi.nlm.nih.gov/31473073/) 6. [Post-approval process: A challenge for ethics committees](https://pubmed.ncbi.nlm.nih.gov/37554242/) 7. [Investigating the Food and Drug Administration Biotherapeutics Review and Approval Process: Narrative Review](https://pubmed.ncbi.nlm.nih.gov/33661119/) 8. [Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process](https://pubmed.ncbi.nlm.nih.gov/29212782/) 9. [Progress and Challenges of the New Conditional Approval Process in China: A Pooled Analysis From 2018 to 2021.](https://pubmed.ncbi.nlm.nih.gov/37806812/)